PDQ® Cancer Integrative, Alternative, and Complementary Therapies Editorial Board
This Board consists of experts in the fields of oncology, pharmacology, natural products, drug discovery and development, traditional Chinese medicine, acupuncture, and homeopathy. The Board also contains representatives from the cancer patient community. This Editorial Board meets quarterly to write and update information summaries on integrative, alternative, and complementary therapies for cancer.
- Jeffrey White, M.D., Editor-in-Chief
National Cancer Institute
Rockville, MD - Donald I. Abrams, M.D.
UCSF Osher Center for Integrative Medicine
San Francisco, CA - Sangeeta Agarawal, R.N., M.S., C.A.S.
Helpsy, Inc.
Sunnyvale, CA - Ting Bao, M.D.
Memorial Sloan-Kettering Cancer Center
New York, NY - John A. Beutler, Ph.D.
National Cancer Institute
Frederick, MD - Keith Block, M.D.
Block Center for Integrative Cancer Treatment
Skokie, IL - Heather Greenlee, N.D., Ph.D, M.P.H.
Fred Hutchinson Cancer Research Center
Seattle, WA - Wayne B. Jonas, M.D.
H&S Ventures
Alexandria, VA - Kara Kelly, M.D.
Women and Children's Hospital of Buffalo, University of Buffalo
Buffalo, NY
- Douglas Kinghorn, Ph.D., D.Sc.
Ohio State University
Columbus, OH - Nagi B. Kumar, Ph.D., R.D., FADA
Moffitt Cancer Center
Tampa, FL - Elena J. Ladas, Ph.D., R.D.
Columbia University
New York, NY - Neal Paul Levitan
Patient Advocate
Cambridge, MA - Jing Li, Ph.D.
Food and Drug Administration
Rockville, MD - Gabriel Lopez, M.D.
M.D. Anderson Cancer Center
Houston, TX - Patrick J. Mansky, M.D.
Frederick Memorial Hospital Regional Cancer Therapy Center
Frederick, MD - Channing Paller, M.D.
Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins Hospital
Washington, DC - Guido F. Pauli, PharmD, Ph.D.
University of Illinois at Chicago
Chicago, IL